The Rising Influence of Rising Affluence

[semi_infinite]

VCEL - Q4 ER. Did beat guidance handily but not as much as my mis-interpretation of Jan. slide deck - slide 20 that suggest sales rate per sales rep is an instantaneous measurement instead of trailing 12 month estimate. MACI sales grew 30%+ and Epicel flat as expected. Don't understand their reasoning but they anticipate burn debridement product Nexobrid will result in single digit growth for all burn products. Guidance is decent for 2020 as they ramp sales regions and sales force. Added some on the dip this AM. Not sure what that was about given strong gross margins and a bottom line that should be rising rapidly from here.

http://investors.vcel.com/news-releases/news-release-details/vericel-reports-fourth-quarter-and-full-year-2019-financial